Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice

Selective serotonin reuptake inhibitors (SSRIs) have been reported to increase cognitive performance in some clinical studies of Alzheimer’s disease (AD). However, there is a lack of evidence supporting the efficacy of SSRIs as cognition enhancers in AD, and the role of SSRIs as a treatment for AD r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jing, Gao, Yuan, Jiang, Lin, Chao, Feng-lei, Huang, Wei, Zhou, Chun-ni, Tang, Wei, Zhang, Lei, Huang, Chun-xia, Zhang, Yi, Luo, Yan-min, Xiao, Qian, Yu, Hua-rong, Jiang, Rong, Tang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper: Gerotarget (Focus on Aging)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438600/
https://www.ncbi.nlm.nih.gov/pubmed/28430602
http://dx.doi.org/10.18632/oncotarget.15398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438600/
https://www.ncbi.nlm.nih.gov/pubmed/28430602
http://dx.doi.org/10.18632/oncotarget.15398

Ejemplares similares